Australian biopharmaceutical company Novogen Ltd. settled its patent lawsuit against health care products company Chattem Inc. on confidential terms, the companies said on Tuesday.
The lawsuit alleged that Chattem sold menopause products that infringed Novogen's U.S. patents for health supplements containing isoflavones _ compounds that are known antioxidants with disease-fighting properties.
Novogen said in recent years it has reached settlements in similar cases against other companies
source:www.chron.com
Wednesday, June 27, 2007
Novogen, Chattem Settle Patent Dispute
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment